Arthur Deboeck,Francis Vanderbist,Philippe Baudier,Antonio Sereno
申请号：
US12385758
公开号：
US20160106699A1
申请日:
2009.04.17
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Oral pharmaceutical composition containing, in the same pharmaceutical form, effective amounts of a HMG-CoA reductase inhibitor derivative and of PPARα, especially fenofibrate. Also described is the use of some inactive ingredients which allow to improve the dissolution and/or bioavailability of the drugs from the said composition.
